BPC-157/TB-500
$79.99
In stock
Dilution notice
If a compound turns cloudy after it is reconstituted, the cause is almost always the reconstitution solution rather than the compound itself, and non-laboratory-grade solutions are the usual culprit. For this reason, cloudiness cannot be accepted as grounds for a refund unless the reconstitution was done using a laboratory-grade reconstitution solution.
Description
This Stack combines BPC-157 and TB-500. Its research context focuses on connective-tissue signaling and the cellular processes involved in repair. BPC-157 studies examine tendon-cell responses and blood-vessel formation, while related thymosin beta-4 research explores cell movement and tissue remodeling.
Research context
- BPC-157 research examines growth-hormone receptor expression in tendon cells involved in connective-tissue maintenance.¹1
- BPC-157 studies investigate blood-vessel formation through VEGFR2, a receptor involved in vascular growth signaling.²2
- BPC-157 studies investigate blood-vessel formation through VEGFR2, a receptor involved in vascular growth signaling.²3
- Chang CH, et al. Molecules. 2014;19(11):19066–19077. DOI:10.3390/molecules191119066. PMID:25415472. PubMed.
- Hsieh MJ, et al. J Mol Med. 2017;95:323–333. DOI:10.1007/s00109-016-1488-y. Publisher paper.
- Goldstein AL, Hannappel E, Kleinman HK. Trends Mol Med. 2005;11(9):421–429. DOI:10.1016/j.molmed.2005.07.004. PMID:16099219. Thymosin beta-4 review. PubMed.
Intended use
Research Use Only. Supplied strictly for laboratory research. Not for use in humans or animals, and not for use in foods, drugs, supplements, or diagnostics.
These statements have not been evaluated by the Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals.
Batch Documentation
Independent Testing History
Review the latest independently tested batch records for this compound.
Keep exploring
